Instil Bio, Inc.
TIL- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001789769
No open-market purchases or sales by Instil Bio, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $29.2M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Instil Bio, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- −4 vs. Q2 2025
- Shares held
- 4.55M
- −96.0K (−2.1%) vs. Q2 2025
- Total value
- $81.3M
- −$15.5M (−16.0%) vs. Q2 2025
- New holders
- 5
- 8 more added
- Sold out
- 9
- 10 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TIL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $29.2M |
| Q1 2026 | 32 | $34.6M |
| Q4 2025 | 29 | $48.9M |
| Q3 2025 | 34 | $81.3M |
| Q2 2025 | 38 | $96.9M |
| Q1 2025 | 43 | $91.2M |
| Q4 2024 | 40 | $100.0M |
| Q3 2024 | 49 | $358.0M |
| Q2 2024 | 30 | $43.5M |
| Q1 2024 | 31 | $45.9M |
| Q4 2023 | 30 | $30.0M |
| Q3 2023 | 58 | $34.3M |
| Q2 2023 | 62 | $45.3M |
| Q1 2023 | 73 | $60.9M |
| Q4 2022 | 79 | $64.1M |
| Q3 2022 | 95 | $577.0M |
| Q2 2022 | 99 | $550.9M |
| Q1 2022 | 79 | $1.27B |
| Q4 2021 | 77 | $1.99B |
| Q3 2021 | 64 | $1.28B |
| Q2 2021 | 62 | $1.35B |
| Q1 2021 | 56 | $1.62B |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Instil Bio, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 1 | $18 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 1 | $18 | 0.00% | +1 | New |
| FMR LLC | 5 | $94 | 0.00% | 00.0% | Unchanged |
| Frazier Financial Advisors, LLC | 15 | $268 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 111 | $1.98K | 0.00% | +111 | New |
| Rhumbline Advisers | 114 | $2.04K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 286 | $5.00K | 0.00% | −49−14.6% | Reduced |
| Bokf, NA | 454 | $8.11K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 599 | $10.7K | 0.00% | −441−42.4% | Reduced |
| BNP Paribas Arbitrage, SA | 3,104 | $55.4K | 0.00% | +377+13.8% | Added |
| Tower Research Capital LLC (TRC) | 3,134 | $56.0K | 0.00% | +2,919+1,357.7% | Added |
| UBS Group AG | 5,621 | $100.4K | 0.00% | −10,598−65.3% | Reduced |
| Barclays PLC | 6,150 | $109.8K | 0.00% | −4,250−40.9% | Reduced |
| Americana Partners, LLC | 10,676 | $190.7K | 0.01% | −2,250−17.4% | Reduced |
| Quest Partners LLC | 14,747 | $263.4K | 0.02% | +6,760+84.6% | Added |
| Northern Trust Corp | 15,684 | $280.1K | 0.00% | −48,729−75.7% | Reduced |
| State Street Corp | 17,595 | $314.2K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 20,802 | $371.5K | 0.00% | +20,802 | New |
| LPL Financial LLC | 33,687 | $601.6K | 0.00% | +33,687 | New |
| Geode Capital Management, LLC | 42,339 | $756.5K | 0.00% | −755−1.8% | Reduced |
| Marshall Wace, LLP | 44,878 | $801.5K | 0.00% | +44,878 | New |
| Macquarie Group Ltd | 50,000 | $893.0K | 0.00% | 00.0% | Unchanged |
| Boxer Capital Management, LLC | 60,700 | $1.08M | 0.35% | −10,000−14.1% | Reduced |
| BlackRock, Inc. | 61,682 | $1.10M | 0.00% | +10,949+21.6% | Added |
| Dimensional Fund Advisors LP | 80,816 | $1.44M | 0.00% | −2,006−2.4% | Reduced |
| Morgan Stanley | 102,938 | $1.84M | 0.00% | +6,630+6.9% | Added |
| Sectoral Asset Management Inc | 161,380 | $2.88M | 1.78% | +75,160+87.2% | Added |
| Vanguard Group Inc | 167,810 | $3.00M | 0.00% | −288−0.2% | Reduced |
| Millennium Management LLC | 196,742 | $3.51M | 0.00% | +88,645+82.0% | Added |
| Siren, L.L.C. | 203,933 | $3.64M | 0.14% | 00.0% | Unchanged |
| Vivo Capital, LLC | 292,743 | $5.23M | 0.42% | 00.0% | Unchanged |
| CPMG Inc | 410,922 | $7.34M | 35.99% | 00.0% | Unchanged |
| BML Capital Management, LLC | 645,600 | $11.5M | 10.61% | +110,701+20.7% | Added |
| Curative Ventures V LLC | 1,899,004 | $33.9M | 100.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −163,261−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −88,796−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −70,655−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −57,497−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −17,369−100.0% | Sold out |
| Exome Asset Management LLC | 0 | $0 | 0.00% | −16,200−100.0% | Sold out |
| GF Fund Management Co. Ltd. | 0 | $0 | 0.00% | −3,000−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −1,433−100.0% | Sold out |
| Eq Wealth Advisors, LLC | 0 | $0 | 0.00% | −40−100.0% | Sold out |